Ann Hepatobiliary Pancreat Surg.  2025 Feb;29(1):62-71. 10.14701/ahbps.24-172.

Impact of soft pancreas on pancreaticoduodenectomy outcomes and the development of the preoperative soft pancreas risk score

• Czarnecka Z
• Verhoeff K
• Bigam D
• Dajani K
• Shapiro J
• Anderson B

• KMID: 2565408
• DOI: http://doi.org/10.14701/ahbps.24-172

Abstract

Backgrounds/Aims
Pancreatic texture is difficult to predict without palpation. Soft pancreatic texture is associated with increased post-operative complications, including postoperative pancreatic fistula (POPF), cardiac, and respiratory complications. We aimed to develop a calculator predicting pancreatic texture using patient factors and to illustrate complications from soft pancreatic texture following pancreaticoduodenectomy.
Methods
Data was collected from the 2016 to 2021 American College of Surgeons National Surgical Quality Improvement database including 17,706 pancreaticoduodenectomy cases. Patients were categorized into two cohorts based on pancreatic texture (9,686 hard, 8,020 soft). Multivariable modeling assessed the impact of patient factors on complications, mortality, and pancreatic texture. These preoperative factors were integrated into a risk calculator (preoperative soft pancreas risk score [PSPRS]) that predicts pancreatic texture.
Results
Patients with a soft pancreas had higher rates of postoperative complications compared to those with a hard pancreas (56.5% vs 42.2%; p < 0.001), particularly a threefold increase in POPF rate, and at least a twofold increase in rates of acute kidney injury, deep organ space infection, septic shock, and prolonged length of stay. Female sex (odds ratio [OR]: 1.14, confidence interval [CI]: 1.06–1.22, p < 0.001) and higher body mass index (OR: 1.12, CI: 1.09–1.16, p < 0.001) were independently associated with a soft pancreas. PSPRS ≥6 correctly identified >40% of patients preoperatively as having a hard pancreas (68.9% specificity).
Conclusions
A soft pancreas was independently associated with serious postoperative complications. Our results were integrated into a risk calculator predicting pancreatic texture from preoperative patient factors, potentially enhancing preoperative counseling and surgical decision-making.

Keyword

Pancreas; Texture; Pancreaticoduodenectomy; Counselling; Risk assessment

Reference

References

1. Hong TH, Choi JI, Park MY, Rha SE, Lee YJ, You YK, et al. 2017; Pancreatic hardness: Correlation of surgeon's palpation, durometer measurement and preoperative magnetic resonance imaging features. World J Gastroenterol. 23:2044–2051. DOI: 10.3748/wjg.v23.i11.2044. PMID: 28373771. PMCID: PMC5360646.

2. Zhang JY, Huang J, Zhao SY, Liu X, Xiong ZC, Yang ZY. 2021; Risk factors and a new prediction model for pancreatic fistula after pancreaticoduodenectomy. Risk Manag Healthc Policy. 14:1897–1906. DOI: 10.2147/RMHP.S305332. PMID: 34007227. PMCID: PMC8121671.

3. Mahvi DA, Pak LM, Urman RD, Gold JS, Whang EE. 2019; Discharge destination following pancreaticoduodenectomy: a NSQIP analysis of predictive factors and post-discharge outcomes. Am J Surg. 218:342–348. DOI: 10.1016/j.amjsurg.2018.11.043. PMID: 30553461.

4. Luu AM, Olchanetski B, Herzog T, Tannapfel A, Uhl W, Belyaev O. 2021; Is primary total pancreatectomy in patients with high-risk pancreatic remnant justified and preferable to pancreaticoduodenectomy? -A matched-pairs analysis of 200 patients. Gland Surg. 10:618–628. DOI: 10.21037/gs-20-670. PMID: 33708545. PMCID: PMC7944076.

5. Zhu F, Wang M, Wang X, Tian R, Shi C, Xu M, et al. 2013; Modified technique of pancreaticogastrostomy for soft pancreas with two continuous hemstitch sutures: a single-center prospective study. J Gastrointest Surg. 17:1306–1311. DOI: 10.1007/s11605-013-2183-8. PMID: 23508688. PMCID: PMC3674402.

6. Kazantsev GB, Spitzer AL, Peng PD, Ramirez RM, Chang CK, Tsai S, et al. 2023; Pancreaticogastrostomy as a fistula mitigating strategy for a high-risk pancreatic anastomosis following pancreaticoduodenectomy. HPB (Oxford). 25:124–135. DOI: 10.1016/j.hpb.2022.10.003. PMID: 36323594.

7. Poon RT, Fan ST, Lo CM, Ng KK, Yuen WK, Yeung C, et al. 2007; External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 246:425–433. discussion 433–425. DOI: 10.1097/SLA.0b013e3181492c28. PMID: 17717446. PMCID: PMC1959348.

8. Hallet J, Theodosopoulos E, Abou-Khalil J, Bertens K, Pelletier JS, Segedi M, et al. 2022; Prevention of postoperative pancreatic fistula after pancreatectomy: results of a Canadian RAND/UCLA appropriateness expert panel. Can J Surg. 65:E135–E142. DOI: 10.1503/cjs.001520. PMID: 35236667. PMCID: PMC8900740.

9. Kambakamba P, Mannil M, Herrera P, Linecker M, Müller P, Kümmerli C, et al. 2020; Machine learning based texture analysis predicts postoperative pancreatic fistula in preoperative non-contrast enhanced computed tomography. HPB. 22(Suppl 2):S384. DOI: 10.1016/j.hpb.2020.04.432.

10. Tirkes T, Yadav D, Conwell DL, Territo PR, Zhao X, Venkatesh SK, et al. 2019; Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. Abdom Radiol (NY). 44:2809–2821. DOI: 10.1007/s00261-019-02049-5. PMID: 31089778. PMCID: PMC6599731.

11. Kolbinger FR, Lambrecht J, Leger S, Ittermann T, Speidel S, Weitz J, et al. 2022; The image-based preoperative fistula risk score (preFRS) predicts postoperative pancreatic fistula in patients undergoing pancreatic head resection. Sci Rep. 12:4064. DOI: 10.1038/s41598-022-07970-2. PMID: 35260701. PMCID: PMC8904506.

12. Tang B, Lin Z, Ma Y, Zhang A, Liu W, Zhang J, et al. 2021; A modified alternative fistula risk score (a-FRS) obtained from the computed tomography enhancement pattern of the pancreatic parenchyma predicts pancreatic fistula after pancreatoduodenectomy. HPB (Oxford). 23:1759–1766. DOI: 10.1016/j.hpb.2021.04.015. PMID: 33975799.

13. American College of Surgeons (ACS). ACS NSQIP participant use data file [Internet]. Available from: https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/participant-use-data-file/. ACS;2022. cited 2024 Feb 1.

14. Pulvirenti A, Ramera M, Bassi C. 2017; Modifications in the International Study Group for Pancreatic Surgery (ISGPS) definition of postoperative pancreatic fistula. Transl Gastroenterol Hepatol. 2:107. DOI: 10.21037/tgh.2017.11.14. PMID: 29354764. PMCID: PMC5763010.

15. Liu X. 2012; Classification accuracy and cut point selection. Stat Med. 31:2676–2686. DOI: 10.1002/sim.4509. PMID: 22307964.

16. Kalayarasan R, Himaja M, Ramesh A, Kokila K. 2023; Radiological parameters to predict pancreatic texture: Current evidence and future perspectives. World J Radiol. 15:170–181. DOI: 10.4329/wjr.v15.i6.170. PMID: 37424737. PMCID: PMC10324497.

17. Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. 2013; A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 216:1–14. DOI: 10.1016/j.jamcollsurg.2012.09.002. PMID: 23122535.

18. Hayashibe A, Kameyama M. 2008; Duct-to-mucosa pancreaticojejunostomies with a hard pancreas and dilated pancreatic duct and duct-to-mucosa pancreaticojejunostomies with a soft pancreas and non-dilated duct. HPB (Oxford). 10:54–57. DOI: 10.1080/13651820701883130. PMID: 18695760. PMCID: PMC2504855.

19. Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. 2005; Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol. 11:2456–2461. DOI: 10.3748/wjg.v11.i16.2456. PMID: 15832417. PMCID: PMC4305634.

20. Agalianos C, Paraskeva K, Gouvas N, Davides D, Dervenis C. 2016; Impact of biliary stenting on surgical outcome in patients undergoing pancreatectomy. A retrospective study in a single institution. Langenbecks Arch Surg. 401:55–61. DOI: 10.1007/s00423-015-1360-5. PMID: 26577461.

21. Zechner D, Knapp N, Bobrowski A, Radecke T, Genz B, Vollmar B. 2014; Diabetes increases pancreatic fibrosis during chronic inflammation. Exp Biol Med (Maywood). 239:670–676. DOI: 10.1177/1535370214527890. PMID: 24719378.

22. Kopljar M, Čoklo M, Krstačić A, Krstačić G, Jeleč V, Zovak M, et al. 2020; Retrorenal fat predicts grade C pancreatic fistula after pancreaticoduodenectomy. ANZ J Surg. 90:2472–2477. DOI: 10.1111/ans.16147. PMID: 32691479.

23. Shamali A, Shelat V, Jaber B, Wardak A, Ahmed M, Fontana M, et al. 2017; Impact of obesity on short and long term results following a pancreatico-duodenectomy. Int J Surg. 42:191–196. DOI: 10.1016/j.ijsu.2017.04.058. PMID: 28461146.

24. Ramsey AM, Martin RC. 2011; Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg. 15:1633–1642. DOI: 10.1007/s11605-011-1502-1. PMID: 21484490.

25. Lee JM, Kim HS, Lee M, Park HS, Kang S, Nahm JH, et al. 2021; Association between pancreatic fibrosis and development of pancreoprivic diabetes after pancreaticoduodenectomy. Sci Rep. 11:23538. DOI: 10.1038/s41598-021-02858-z. PMID: 34876608. PMCID: PMC8651673.

26. Erstad DJ, Sojoodi M, Taylor MS, Jordan VC, Farrar CT, Axtell AL, et al. 2020; Fibrotic response to neoadjuvant therapy predicts survival in pancreatic cancer and is measurable with collagen-targeted molecular MRI. Clin Cancer Res. 26:5007–5018. DOI: 10.1158/1078-0432.CCR-18-1359. PMID: 32611647. PMCID: PMC7980315.

27. Moten AS. 2024; Fibrosis following neoadjuvant treatment of PDAC: less is not always more. Am J Surg. 232:8. DOI: 10.1016/j.amjsurg.2023.12.001. PMID: 38092641.

28. Mungroop TH, Klompmaker S, Wellner UF, Steyerberg EW, Coratti A, D'Hondt M, et al. European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). 2021; Updated alternative fistula risk score (ua-FRS) to include minimally invasive pancreatoduodenectomy: pan-european validation. Ann Surg. 273:334–340. DOI: 10.1097/SLA.0000000000003234. PMID: 30829699.

29. Wang M, Gorelick F, Bhargava A. 2021; Sex differences in the exocrine pancreas and associated diseases. Cell Mol Gastroenterol Hepatol. 12:427–441. DOI: 10.1016/j.jcmgh.2021.04.005. PMID: 33895424. PMCID: PMC8255941.

30. Schuh F, Mihaljevic AL, Probst P, Trudeau MT, Müller PC, Marchegiani G, et al. 2023; A simple classification of pancreatic duct size and texture predicts postoperative pancreatic fistula: a classification of the International Study Group of Pancreatic Surgery. Ann Surg. 277:e597–e608. DOI: 10.1097/SLA.0000000000004855. PMID: 33914473. PMCID: PMC9891297.

31. Verdeyen N, Gryspeerdt F, Abreu de Carvalho L, Dries P, Berrevoet F. 2024; A comparison of preoperative predictive scoring systems for postoperative pancreatic fistula after pancreaticoduodenectomy based on a single-center analysis. J Clin Med. 13:3286. DOI: 10.3390/jcm13113286. PMID: 38892998. PMCID: PMC11172640.

32. Balzano G, Zerbi A, Aleotti F, Capretti G, Melzi R, Pecorelli N, et al. 2023; Total pancreatectomy with islet autotransplantation as an alternative to high-risk pancreatojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 277:894–903. DOI: 10.1097/SLA.0000000000005713. PMID: 36177837. PMCID: PMC10174105.

33. Gueroult S, Parc Y, Duron F, Paye F, Parc R. Completion pancreatectomy for postoperative peritonitis after pancreaticoduodenectomy: early and late outcome. Arch Surg. 2004; 139:16–19. DOI: 10.1001/archsurg.139.1.16. PMID: 14718268.

34. Marchegiani G, Perri G, Burelli A, Zoccatelli F, Andrianello S, Luchini C, et al. 2022; High-risk pancreatic anastomosis versus total pancreatectomy after pancreatoduodenectomy: postoperative outcomes and quality of life analysis. Ann Surg. 276:e905–e913. DOI: 10.1097/SLA.0000000000004840. PMID: 33914471.

35. Stoop TF, Ghorbani P, Scholten L, Bergquist E, Ateeb Z, van Dieren S, et al. 2022; Total pancreatectomy as an alternative to high-risk pancreatojejunostomy after pancreatoduodenectomy: a propensity score analysis on surgical outcome and quality of life. HPB (Oxford). 24:1261–1270. DOI: 10.1016/j.hpb.2021.12.018. PMID: 35031280.

36. Rykina-Tameeva N, Nahm CB, Mehta S, Gill AJ, Samra JS, Mittal A. 2020; Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma. HPB (Oxford). 22:1631–1636. DOI: 10.1016/j.hpb.2020.03.007. PMID: 32247587.

37. Deig CR, Sutton TL, Beneville B, Trone K, Stratton A, Gunesch AN, et al. 2022; Neoadjuvant therapy is associated with improved chemotherapy delivery and overall survival compared to upfront resection in pancreatic cancer without increasing perioperative complications. Cancers (Basel). 14:609. DOI: 10.3390/cancers14030609. PMID: 35158877. PMCID: PMC8833799.

38. Rompen IF, Merz DC, Alhalabi KT, Klotz R, Kalkum E, Pausch TM, et al. 2023; Perioperative drug treatment in pancreatic surgery-a systematic review and meta-analysis. J Clin Med. 12:1750. DOI: 10.3390/jcm12051750. PMID: 36902534. PMCID: PMC10003556.